Pfizer (PFE)

SG&A Expense Growth

15.20%

Quarterly · Period ending:

PFE logo

PFE SG&A Expense Growth

Latest reported15.20%
PFE Quarterly SG&A Growth (QoQ) (0.00% → 15.20%)
High-resolution chart · PNG

PFE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
15.1976%
-20.7017%
17.2003%
-6.3492%
12.5%
-28.443%
30.5127%
-12.2017%
6.6204%
-22.6174%
39.1656%
-6.4103%
2.2341%
-24.1699%
36.0479%
11.6678%
15.6808%
-36.4691%
44.2343%
-2.7591%
4.202%
-26.0763%
39.9695%
1.0015%
2.7712%
-40.057%
30.1823%
-7.3555%
4.9564%
-16.4827%
14.6391%
-1.3897%
3.8586%
-25.0552%
30.2473%
1.8448%
3.5162%
-24.9886%
24.3778%
1.8727%
2.5406%
-32.9437%
54.3731%
-3.4259%
9.0851%
-22.0492%
11.9798%
1.0227%
15.7895%
-26.7823%
22.2975%
-5.4581%
0.1674%
-25.5452%
25.1625%
-3.2688%
-3.7745%
-23.0497%
16.2303%
-7.0782%
10.4375%
-21.5232%
-17.8643%
45.3297%
8.3634%
-17.3467%
63.5283%
-2.0299%
16.4812%
-21.3993%
3.8603%
-8.8014%
10.6243%
-24.9516%
23.4873%
-1.9771%
14.3707%
-26.3262%
21.6209%
-3.3497%
1.8635%
-19.8738%
20.9616%
-6.9806%
3.4517%
-12.639%
15.8573%
-5.2137%
8.2634%
-15.9974%
15.8051%
7.1561%
37.5%
31.4176%
-29.1242%
-1.2404%
5.4436%
-12.6313%
21.228%
-4.9466%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.